Skip to main content
Gastroenterology and Hepatology From Bed to Bench logoLink to Gastroenterology and Hepatology From Bed to Bench
. 2018 Winter;11(Suppl 1):S134–S139.

Immunocompromised patients with pulmonary tuberculosis; a susceptible group to intestinal parasites

Ali Taghipour 1, Taher Azimi 2, Ehsan Javanmard 3, Ali Pormohammad 4, Meysam Olfatifar 5, Ali Rostami 6, Payam Tabarsi 7, Mohammad Reza Sohrabi 8, Hamed Mirjalali 3, Ali Haghighi 1
PMCID: PMC6347986  PMID: 30774820

Abstract

Aim:

To investigate the presence of intestinal parasites in tuberculosis patients who suffered from immunodeficiency disorders.

Background:

Tuberculosis is an important infectious disease that is endemic in some regions of Iran. However, there is a coverage in the endemicity areas of this infection with intestinal parasites.

Methods:

Stool samples were collected from 50 immunocompromised tuberculosis patients. Direct smear using the normal saline (0.85% NaCl solution) and Lugol’s iodine staining were performed to detect trophozoite of parasites. Moreover, stool samples were concentrated using routine formalin-ether to detect protozoan cysts and helminth’s ova/larvae. Specific staining techniques including Trichrome, Modified Ziehl-Neelsen and chromotrope 2R were employed to detect amoeba, Giardia spp., coccidian parasites and microsporidia.

Results:

From 50 participants, 42 (84%) and 8 (16%) were male and female, respectively. The mean age + SD of patients was 47.88 + 10.88 years. Among the participated patients, HIV positive, cancer, organ transplant and receiving corticosteroids were seen in 13, 10, 15 and 12 subjects, respectively. The prevalence of Intestinal parasites was 34 %( 17/50). Blastocystis (18%; 9/50), and intestinal helminth (Enterobius vermicularis) (2%; 1/50) were the most prevalent and less prevalent parasites, respectively. Statistical significance difference was not seen between presence of intestinal parasites and type of immunodeficiency.

Conclusion:

Our findings showed the high prevalence of intestinal parasites with majority of Blastocystis. Indeed, this study suggested that due to complicated immune conditions of TB patients with immunodeficiency disorders, this group of patients are at higher risk of infection by intestinal parasites.

Key Words: Tuberculosis, Immunodeficiency disorders, Intestinal parasites, Iran

Introduction

During the years, pulmonary tuberculosis (TB) remains as one of the main reasons of death resulted from infectious diseases (1, 2). Based on the published reports of World Health Organization (WHO), the incidence rate of TB was 10 million with 1.3 million deaths among HIV-negative people and 300000 deaths among HIV-positive people. At the national level, the incidence of TB was 16 per 100000, In Iran (3, 4). In recent years, couple of studies investigated the co-infection of TB and intestinal parasitic infections (IPIs), including protozoans and helminths (5, 6).

Based on published data, it seems that co-existence of these infectious agents has being emerged as a public health issue, particularly in developing countries (7, 8). Moreover, according to the worldwide reports of 2010, 438.9 million, 819 million and 467.6 million people were estimated to be infected with hookworms, Ascaris lumbricoides, and Trichuris trichiura, respectively (9). Presumably, concerning the vast distribution of intestinal parasites, socio-economic conditions are associated with the increase of the incidence of tuberculosis and IPIs in low-income populations (10-12).

On the other hand, presence of immunodeficiency disorders probably increase the complications in TB patients. The high prevalence of intestinal parasitic infections (IPIs) in immunocompromised TB patients (IC-TB) could be related with many factors such as lower CD4 T-cell count, poor hygiene, rural life, lack of nutritious foods and lack of refined drinking water (13-15). Importantly, intestinal helminths are able to strength Th2 immune response via induction of cytokines such as: IL-4, IL-5, and IL-13. Accordingly, change from Th1 toward Th2 during parasitic infection can pull down Th1 immune response to mycobacterium tuberculosis. Totally, the interaction between helminths and TB infections is unclear and controversial, thus so far to be completely understood (16, 17).

Therefore, concerning the endemicity of TB and IPIs and emerging of immunodeficiency disorders, there is a little data in co-existence of TB, IPIs and immunodeficiency disorders. However, the current study aimed to investigate the prevalence of intestinal parasites among pulmonary tuberculosis patients who suffer from immunodeficiency disorders.

Methods

Study population

The current study received the ethic permission of the Ethics Committee of the Shahid Beheshti University of Medical Science (Number: IR.SBMU.MSP.REC.1395.323). Sample collection was conducted during February 2017 to May 2018 from Masih Daneshvari Hospital (the referral center for tuberculosis in Iran). A total of 50 IC-TB patients who were registered in the TB surveillance system and were undergoing anti-MTB treatment, participated in the current study. Prescription of anti-parasitic drugs during three-month prior to sample collection was considered as exclusion criterion. Stool samples were collected in a clean plastic containers and together with filled standard questionnaire (including demographic data, socio-economic features and risk factors related with IPIs) and a signed informed consent, were immediately transformed to parasitology laboratory.

Fecal sample collection and parasitological analysis

In order to detect intestinal parasites, standard methods consisted of direct smear using the normal saline (0.85% NaCl solution) and Lugol’s iodine staining were performed for detection of protozoal trophozoite and cyst, respectively. Moreover, stool samples were concentrated using routine formalin-ether in order to detect protozoan cysts and helminth’s ova/larvae. Specific staining including Trichrome was employed to identify intestinal protozoans such as Giardia lamblia and Entamoeba histolytica. Modified Ziehl-Neelsen and chromotrope 2R staining were used for detection of Cryptosporidium spp. oocysts and microsporidia spores, respectively. All slides were examined under light microscopy (Zeiss, Germany) with 10×, 40× and 100× magnifications.

Statistical analysis

Data analysis was performed using STATA software version 14.2. The frequency and percentages of intestinal parasites and other descriptive were calculated by binomial distribution. The Chi square and Fisher's exact tests were used to compare prevalence of parasites among groups regarding socioeconomic risk factors. P values <0.05 were considered statistically significant.

Results

A total of 50 IC-TB patients including 13 HIV positive subjects, 10 cancer patients (receiving chemotherapies), 15 organ transplant recipients and 12 immunocompromised patients receiving corticosteroids participated in the current study. From 50 participants 42 (84%) and 8 (16%) were male and female, respectively with mean age (±SD) of 47.88±10.88 years. Demographic data and socioeconomic factors are summarized in table1 (Table 1).

Table 1.

Demographic characteristics and Risk Factors of IC-TBP, according to the IPIs

Variable No tested (IC-TBP) (%) Number of infected (%) P value
Sex 0.08
Male 42 (82) 12 (70.58)
Female 8 (18) 5 (29.42)
Age 0.80
≤50 24 (48) 8 (47.05)
>51 26 (52) 9 (52.95)
Residence 0.08
Urban 35 (70) 5 (29.41)
Rural 15 (30) 12 (70.59)
Education 0.80
Primary school 14 (28) 9 (52.94)
High school and above 36(72) 8 (47.06)
Occupation 0.22
Employed 25 (50) 11 (64.70)
Unemployed 25 (50) 6 (35.30)
Consumption fruit and vegetable in rainy weeks 0.02*
Yes 14 (28) 7 (41.17)
No 36 (72) 10 (58.83)
Hand washing before eating 0.22
Yes 32 (64) 11 (64.70)
No 18 (36) 6 (35.30)

In addition, statistical analysis showed that there was a statistical significant correlation between consumption of fruits and vegetables in rainy seasons and presence of IPIs (P value = 0.02), while there was no statistical significant association between presence of intestinal parasites and other risk factors (Table 2).

Table 2.

Prevalence of the IPIs among immunocompromised patients who suffered from TB

Parasites HIV/n=13 (N %) Cancer/n=10 (N %) Transplantation/n=15 (N %) Consumption of corticosteroids/n=12 (N %) Total/IC-TBP (N %) P value
Blastocystis spp. 4 (30.76) 2 (20) 2 (13.33) 1 (8.33) 9 (18) 0.54
Giardia lamblia 1 (7.69) 1 (10) 0 0 2 (4) -
microsporidia 0 1 (10) 0 0 1 (2) -
Cryptosporidium spp. 1 (7.69) 1 (10) 1 (6.66) 0 3 (6) -
Entamoeba coli. 0 0 1 (6.66) 0 1 (2) -
Endolimax nana 1 (7.69) 1 (10) 2 (13.33) 0 4 (8) 0.77
Trichomonas hominis 0 0 1 (6.66) 0 1 (2) -
Chilomastix 0 0 0 1 (8.33) 1 (2) -
Enterobious vermicularis 1 (7.69) 0 0 0 1 (2) -
Number of infected by protozoa 6 (46.15) 4 (40) 5 (33.33) 2 (16.66) 17 (34) 0.56
Number of infected by helminths 1 (7.69) 0 0 0 1 (2) -

The results of parasitological examination showed the prevalence 34 %( 17/50) of IPIs among the patients. Accordingly, Blastocystis was the most prevalent IPIs (18%; 9/50) in all groups of IC-TB patients, while only one patient in HIV-TB group (2%; 1/50) was infected with intestinal helminths (Enterobius vermicularis). Moreover, the highest prevalence of IPIs was seen among those TB patients who were positive for HIV, while the less prevalence of IPIs was observed among TB patients who received immunosuppressive drugs. However, statistical significance difference was not seen between presence of intestinal parasites and type of immunodeficiency (Table 2).

Discussion

TB and IPIs have been considered as public health issues in low- and middle-income countries. The results of present study showed that the total prevalence of IPIs among IC-TB patients was 34 %. This prevalence rate is approximately in accordance with previous comprehensive studies in Iran that showed the overall prevalence of IPIs among immunocompromised patients 11.7% (18), hemodialysis patients 30% (19) and patients with gastrointestinal disorders 32% (20). Moreover, the prevalence of IPIs in present study among IC-TB patients was similar to the results reported in Ethiopia as 40% (21). Interestingly, the prevalence of IPIs in the current study was higher than the study in China conducted by Li et al. who reported the prevalence of 7.3% (22) and 14.9% (10) in TB patients without HIV. This finding indicates that presence of immunodeficiency in TB patients can make them more susceptible to IPIs in comparison with TB patients without immunodeficiency and also healthy subjects. Furthermore, the results of other studies in Iran on the prevalence of IPIs in hemodialysis individuals (19, 23) and immunocompromised patients (18, 24, 25) support our findings. However, it was suggested that patients with immunodeficiency disorders are at higher risk of IPIs in comparison with immunocompetent subjects that the reason of this fact is correlated with insufficiency in immune response to the parasites in this group of patients (26).

In the current study, the highest prevalence of IPIs was seen among TB patients who infected with HIV. However, there are studies that reported the role of HIV in shifting of immune response from Th1 toward Th2. Notably, defense against helminth parasites is mainly mediated by Th2 immune responses and thus, imbalance of immune response resulted from HIV, helminth parasites and/or both of them, makes human subjects more susceptible to TB (27, 28). On the other hand, co-existence of TB, intestinal parasites and HIV can be resulted from socioeconomic conditions of an area. In another words, all of these infectious agents are more prevalent in the regions with low level of hygiene and income.

Apart from HIV that affects the immune system via an infectious agent, the other mentioned immunodeficiency disorders in the current study happened due to consumption of corticosteroids or immunesuppressor agents (29). However, there are several reports that indicated the role of consumption of corticosteroids or immunesuppressor drugs in modulation of immune response to infectious agents (30, 31). Although in the current we did not have data about the fact that TB or intestinal parasites/immunodeficiency disorders were firstly raised in the studied patients, it seems that presence of each of them can provide suitable conditions for infection by the other agents. In other words, consumption of immunosuppressor drugs attenuates overall immune response and makes human subjects prone to secondary infection by TB or intestinal parasites, particularly opportunistic infections (32).

Furthermore, findings of the current study showed that consumption of raw vegetables and fruits, particularly in rainy seasons, increases the risk of IPIs in susceptible subjects especially TB patients who suffer from immunodeficiency disorders. The increased risk of transmission of intestinal parasites to human via eating raw vegetable and fruits were frequently reported. Bekele and colleagues showed that 54.4% of vegetable and fruit samples were contaminated with intestinal parasites (33). In Iran, Asadpour and colleagues reported that 36.8% of farm vegetables were contaminated with intestinal parasites (34). In another study, Javanmard and colleagues showed that 41.7% of farm vegetables were seen contaminated with intestinal parasites (35). The high prevalence of intestinal parasites in raw vegetable and fruits supports our finding that showed statistical correlation between consumption of raw vegetables and presence of intestinal parasites in a susceptible group such as TB patients with immunodeficiency disorders.

However, it is proposed that co-existence of TB and acquired immune deficiencies provides a complicated immune conditions that make patients more prone to intestinal parasites. In addition, socio-economic conditions, especially in developing countries can enhance the risk of co-infection of TB and intestinal parasites.

In the current study, intestinal parasites were observed amongst 34% of TB patients who suffer from immunodeficiency disorders. In addition, the highest prevalence of IPIs was seen in TB patients with HIV. However, TB patients due to immune response to Mycobacterium tuberculosis, experience complicated condition that make them more prone to particularly helminths parasites. This intricate issue would be worst if this group of patient suffers from an immunodeficiency disorder. Therefore, it seems that TB patients with immunodeficiency are probably more susceptible to gastrointestinal infections, particularly parasites. Thus, providing a suitable personal hygiene and also regular health checkup for intestinal parasites are recommended.

Acknowledgment

The authors appreciate all scientists and personnel of Medical Parasitology and Mycology Department in Shahid Beheshti University of Medical Sciences, Tehran, especially Dr. SJ Seyyed Tabaei, Mrs. N. Taghipour, Dr. F. Bahrami, and Dr. Z. Lasjerdi for their helpful comments and collaborations. This study was a part of the MSc thesis of Ali Taghipour which was financially supported by National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences (Grant No. code: 11339)..

Conflict of interests

The authors declare that they have no conflict of interest.

References

  • 1.Dye C. Global epidemiology of tuberculosis. Lancet. 2006;367:938–40. doi: 10.1016/S0140-6736(06)68384-0. [DOI] [PubMed] [Google Scholar]
  • 2.Zhou A, Nawaz M, Xue X, Karakousis PC, Yao Y, Xu J. Molecular genotyping of Mycobacterium tuberculosis in Xi'an, China, using MIRU-VNTR typing. Int J Tuberc Lung Dis. 2011;15:517–22. doi: 10.5588/ijtld.10.0495. [DOI] [PubMed] [Google Scholar]
  • 3.WHO. Global tuberculosis report 2017. World Health Organization; [Google Scholar]
  • 4.Azimi T, Nasiri MJ, Zamani S, Hashemi A, Goudarzi H, Fooladi AAI, et al. High genetic diversity among Mycobacterium tuberculosis strains in Tehran, Iran. J Clin Tuberc Other Mycobact Dis. 2018;11:1–6. doi: 10.1016/j.jctube.2018.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Taghipour N, Aghdaei HA, Haghighi A, Mossafa N, Tabaei SJ, Rostami-Nejad M. Potential treatment of inflammatory bowel disease: a review of helminths therapy. Gastroenterol Hepatol Bed Bench. 2014;7:9–16. [PMC free article] [PubMed] [Google Scholar]
  • 6.Tegegne Y, Wondmagegn T, Worku L, Jejaw Zeleke A. Prevalence of Intestinal Parasites and Associated Factors among Pulmonary Tuberculosis Suspected Patients Attending University of Gondar Hospital, Gondar, Northwest Ethiopia. J Parasitol Res. 2018;2018:9372145. doi: 10.1155/2018/9372145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Elias D, Britton S, Kassu A, Akuffo H. Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Rev Anti Infect Ther. 2007;5:475–84. doi: 10.1586/14787210.5.3.475. [DOI] [PubMed] [Google Scholar]
  • 8.Lloyd-Smith JO, Poss M, Grenfell BT. HIV-1/parasite co-infection and the emergence of new parasite strains. Parasitology. 2008;135:795–806. doi: 10.1017/S0031182008000292. [DOI] [PubMed] [Google Scholar]
  • 9.Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasit Vectors. 2014;7:37. doi: 10.1186/1756-3305-7-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rostami Nejad M, Nazemalhosseini Mojarad E, Nochi Z, Fasihi Harandi M, Cheraghipour K, Mowlavi GR, et al. Echinococcus granulosus strain differentiation in Iran based on sequence heterogeneity in the mitochondrial 12S rRNA gene. J Helminthol. 2008;82:343–47. doi: 10.1017/S0022149X0804594X. [DOI] [PubMed] [Google Scholar]
  • 11.Rezaei Riabi T, Haghighi A, Mirjalali H, Mohammad Ali Gol S, Karamati SA, Ghasemian M, et al. Study of prevalence, distribution and clinical significance of Blastocystis isolated from two medical centers in Iran. Gastroenterol Hepatol Bed Bench. 2017;10:S102–7. [PMC free article] [PubMed] [Google Scholar]
  • 12.Haghighi A, Riahi SM, Taghipour A, Spotin A, Javanian M, Mohammadi M, et al. Amoebiasis in Iran: a systematic review and meta-analysis. Epidemiol Infect. 2018;146:1880–90. doi: 10.1017/S0950268818001863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lewthwaite P, Gill GV, Hart CA, Beeching NJ. Gastrointestinal parasites in the immunocompromised. Curr Opin Infect Dis. 2005;18:427–35. doi: 10.1097/01.qco.0000182104.40128.18. [DOI] [PubMed] [Google Scholar]
  • 14.Pestechian N, Rasekh H, Rostami-Nejad M, Yousofi HA, Hosseini-Safa A. Molecular identification of Giardia lamblia; is there any correlation between diarrhea and genotyping in Iranian population? Gastroenterol Hepatol Bed Bench. 2014;7:168–72. [PMC free article] [PubMed] [Google Scholar]
  • 15.Assefa S, Erko B, Medhin G, Assefa Z, Shimelis T. Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count. BMC Infect Dis. 2009;9:155. doi: 10.1186/1471-2334-9-155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Elias D, Mengistu G, Akuffo H, Britton S. Are intestinal helminths risk factors for developing active tuberculosis? Trop Med Int Health. 2006;11:551–8. doi: 10.1111/j.1365-3156.2006.01578.x. [DOI] [PubMed] [Google Scholar]
  • 17.Salgame P, Yap GS, Gause WC. Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol. 2013;14:1118–26. doi: 10.1038/ni.2736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rasti S, Hassanzadeh M, Hooshyar H, Momen-Heravi M, Mousavi SGA, Abdoli A. Intestinal parasitic infections in different groups of immunocompromised patients in Kashan and Qom cities, central Iran. Scand J Gastroenterol. 2017;52:738–41. doi: 10.1080/00365521.2017.1308547. [DOI] [PubMed] [Google Scholar]
  • 19.Omrani VF, Fallahi Sh, Rostami A, Siyadatpanah A, Barzgarpour G, Mehravar S, et al. Prevalence of intestinal parasite infections and associated clinical symptoms among patients with end-stage renal disease undergoing hemodialysis. Infection. 2015;43:537–44. doi: 10.1007/s15010-015-0778-6. [DOI] [PubMed] [Google Scholar]
  • 20.Kiani H, Haghighi A, Rostami A, Azargashb E, Tabaei SJ, Solgi A, et al. Prevalence, risk factors and symptoms associated to intestinal parasite infections among patients with gastrointestinal disorders in nahavand, western iran. Rev Inst Med Trop Sao Paulo. 2016;58:42. doi: 10.1590/S1678-9946201658042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kassu A, Mengistu G, Ayele B, Diro E, Mekonnen F, Ketema D, et al. HIV and intestinal parasites in adult TB patients in a teaching hospital in Northwest Ethiopia. Trop Doct. 2007;37:222–4. doi: 10.1258/004947507782333026. [DOI] [PubMed] [Google Scholar]
  • 22.Li XX, Chen JX, Wang LX, Tian LG, Zhang YP, Dong SP, et al. Prevalence and risk factors of intestinal protozoan and helminth infections among pulmonary tuberculosis patients without HIV infection in a rural county in P. R. China. Acta Trop. 2015;149:19–26. doi: 10.1016/j.actatropica.2015.05.001. [DOI] [PubMed] [Google Scholar]
  • 23.Seyrafian S, Pestehchian N, Kerdegari M, Yousefi HA, Bastani B. Prevalence rate of Cryptosporidium infection in hemodialysis patients in Iran. Hemodial Int. 2006;10:375–9. doi: 10.1111/j.1542-4758.2006.00133.x. [DOI] [PubMed] [Google Scholar]
  • 24.Zali MR, Mehr AJ, Rezaian M, Meamar AR, Vaziri S, Mohraz M. Prevalence of intestinal parasitic pathogens among HIV-positive individuals in Iran. Jpn J Infect Dis. 2004;5:268–70. [PubMed] [Google Scholar]
  • 25.Rostami Nejad M, Rostami K, Cheraghipour K, Nazemalhosseini Mojarad E, Volta U, Al Dulaimi D, et al. Celiac disease increases the risk of Toxoplasma gondii infection in a large cohort of pregnant women. Am J Gastroenterol. 2011;106:548–9. doi: 10.1038/ajg.2010.425. [DOI] [PubMed] [Google Scholar]
  • 26.Taremi M, Soltan Dallal M, Gachkar L, Moez Ardalan S, Zolfagharian K, Reza Zali M. Prevalence and antimicrobial resistance of Campylobacter isolated from retail raw chicken and beef meat, Tehran, Iran. Int J Food Microbiol. 2006;108:401–403. doi: 10.1016/j.ijfoodmicro.2005.12.010. [DOI] [PubMed] [Google Scholar]
  • 27.Babu S, Nutman TB. Helminth-Tuberculosis Co-infection: An Immunologic Perspective. Trends Immunol. 2016;37:597–607. doi: 10.1016/j.it.2016.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol. 2001;123:219–25. doi: 10.1046/j.1365-2249.2001.01446.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mwambete K, Justin-Temu M. Challenges of secondary immunodeficiency and drug resistant opportunistic pathogens in developing countries. FORMATEX. 2013 [Google Scholar]
  • 30.Hill RB Jr, ROWLANDS DT Jr, RIFKIND D. infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation. N Engl J Med. 1964;271:1021–7. doi: 10.1056/NEJM196411122712001. [DOI] [PubMed] [Google Scholar]
  • 31.Tajbakhsh M, García Migura L, Rahbar M, Svendsen CA, Mohammadzadeh M, et al. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? J Antimicrob Chemother. 2012;67:1128–33. doi: 10.1093/jac/dks023. [DOI] [PubMed] [Google Scholar]
  • 32.Bekele F, Tefera T, Biresaw G, Yohannes T. Parasitic contamination of raw vegetables and fruits collected from selected local markets in Arba Minch town,Southern Ethiopia. Infect Dis Poverty. 2017;6:19. doi: 10.1186/s40249-016-0226-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Asadpour M, Malekpour H, Jafari A, Bahrami S. Diversity of parasitic contamination in raw vegetables commonly consumed in Shiraz, southwest of Iran. Asian Pac J Trop Dis. 2016;6:160–2. [Google Scholar]
  • 35.Javanmard E, Mirjalali H, Niyyati M, Sharifdini M, Jalilzadeh E, Seyed Tabaei SJ, et al. Small-scale risk assessment of transmission of parasites from astewater treatment plant to downstream vegetable farms. Gastroenterol Hepatol Bed Bench. 2018l;11:352–358. [PMC free article] [PubMed] [Google Scholar]

Articles from Gastroenterology and Hepatology From Bed to Bench are provided here courtesy of Shahid Beheshti University of Medical Sciences

RESOURCES